XML 19 R5.htm IDEA: XBRL DOCUMENT v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
Common Stock
Additional Paid- in Capital
Accumulated Deficit
Total
Beginning Balance at Dec. 31, 2022 $ 8,406 $ 447,641,680 $ (428,049,049) $ 19,601,037
Beginning Balance, Shares at Dec. 31, 2022 8,405,771      
Shares purchased pursuant to ATM agreement $ 213 619,761   619,974
Shares purchased pursuant to ATM agreement (in shares) 212,761      
Issuance of common stock as commitment fee for future financing $ 180 (180)    
Issuance of common stock as commitment fee for future financing (in shares) 180,410      
Issuance of common stock from exercise of stock options   736   736
Issuance of common stock from exercise of stock options (in shares) 344      
Stock-based compensation   1,264,792   1,264,792
Net loss     (2,451,787) (2,451,787)
Fractional shares adjustment due to reverse split (113)      
Ending Balance at Jun. 30, 2023 $ 8,799 449,526,789 (430,500,836) 19,034,752
Ending Balance, Shares at Jun. 30, 2023 8,799,173      
Beginning Balance at Mar. 31, 2023 $ 8,799 448,921,174 (433,016,625) 15,913,348
Beginning Balance, Shares at Mar. 31, 2023 8,798,829      
Issuance of common stock from exercise of stock options   736   736
Issuance of common stock from exercise of stock options (in shares) 344      
Stock-based compensation   604,879   604,879
Net loss     2,515,789 2,515,789
Ending Balance at Jun. 30, 2023 $ 8,799 449,526,789 (430,500,836) 19,034,752
Ending Balance, Shares at Jun. 30, 2023 8,799,173      
Beginning Balance at Dec. 31, 2023 $ 8,891 450,329,515 (436,285,863) 14,052,543
Beginning Balance, Shares at Dec. 31, 2023 8,891,420      
Shares purchased pursuant to ATM agreement $ 8 36,894   36,902
Shares purchased pursuant to ATM agreement (in shares) 8,178      
Issuance of common stock from exercise of stock options $ 23 56,777   $ 56,800
Issuance of common stock from exercise of stock options (in shares) 23,097     23,097
Stock-based compensation   142,018   $ 142,018
Net loss     (4,585,499) (4,585,499)
Ending Balance at Jun. 30, 2024 $ 8,922 450,565,204 (440,871,362) 9,702,764
Ending Balance, Shares at Jun. 30, 2024 8,922,695      
Beginning Balance at Mar. 31, 2024 $ 8,910 450,458,009 (438,678,685) 11,788,234
Beginning Balance, Shares at Mar. 31, 2024 8,910,917      
Shares purchased pursuant to ATM agreement $ 8 36,894   36,902
Shares purchased pursuant to ATM agreement (in shares) 8,178      
Issuance of common stock from exercise of stock options $ 4 7,700   7,704
Issuance of common stock from exercise of stock options (in shares) 3,600      
Stock-based compensation   62,601   62,601
Net loss     (2,192,677) (2,192,677)
Ending Balance at Jun. 30, 2024 $ 8,922 $ 450,565,204 $ (440,871,362) $ 9,702,764
Ending Balance, Shares at Jun. 30, 2024 8,922,695